Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,223 INR | -0.37% | -12.89% | +17.70% |
May. 14 | Transcript : Neuland Laboratories Limited, Q4 2024 Earnings Call, May 14, 2024 | |
May. 10 | Neuland Laboratories' Consolidated Profit Declines in Fiscal Q4 | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+17.70% | 960M | |
+33.08% | 709B | |
+30.77% | 595B | |
-2.28% | 367B | |
+20.15% | 334B | |
+5.13% | 289B | |
+14.77% | 239B | |
+9.13% | 211B | |
-3.97% | 203B | |
+8.89% | 171B |
- Stock Market
- Equities
- NEULANDLAB Stock
- News Neuland Laboratories Limited
- Neuland Laboratories Limited Approves the Resignation of Anil Kumar as Chief Financial Officer, with Effect from February 28, 2017